XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income including non-controlling interests $ 599,153 $ 46,044
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:    
Depreciation, depletion and amortization 86,809 78,958
Gain on sale of assets (520,740) (223,068)
Impairment 0 5
Deferred income taxes (7) 0
Net loss on derivative instruments 466,175 448,552
Net loss from investment in unconsolidated affiliate 36,116 0
Equity-based compensation expenses 9,663 6,900
Deferred financing costs amortization and other 3,294 16,289
Working capital and other changes:    
Change in accounts receivable, net (112,688) (96,704)
Change in inventory (14,040) (2,880)
Change in prepaid expenses 1,035 3,773
Change in accounts payable, interest payable and accrued liabilities 96,141 80,969
Change in other assets and liabilities, net 11,080 (8,475)
Net cash provided by operating activities 661,991 350,363
Cash flows from investing activities:    
Capital expenditures (114,325) (85,217)
Acquisition deposit 0 (74,500)
Proceeds from divestitures, net of OMP cash 148,818 369,819
Costs related to divestitures (11,368) (2,358)
Derivative settlements (201,668) (78,575)
Derivative modification 0 (82,419)
Distributions from investment in unconsolidated affiliate 26,862 0
Net cash provided by (used in) investing activities (151,681) 46,750
Cash flows from financing activities:    
Proceeds from revolving credit facilities 15,000 369,500
Principal payments on revolving credit facilities 0 (866,500)
Proceeds from issuance of senior unsecured notes 0 850,000
Deferred financing costs (9) (20,332)
Proceeds from issuance of OMP common units, net of offering costs 0 86,657
Common control transaction costs 0 (5,432)
Purchases of treasury stock 0 (14,560)
Tax withholding on vesting of equity-based awards (4,789) 0
Dividends paid (139,860) (15,039)
Distributions to non-controlling interests 0 (12,165)
Payments on finance lease liabilities (229) (726)
Proceeds from warrants exercised 15,908 173
Net cash provided by (used in) financing activities (113,979) 371,576
Increase in cash and cash equivalents 396,331 768,689
Cash and cash equivalents:    
Beginning of period 174,783 20,226
End of period 571,114 788,915
Supplemental non-cash transactions:    
Change in accrued capital expenditures (806) 11,515
Change in asset retirement obligations (428) (1,370)
Investment in unconsolidated affiliate 568,312 0
Note receivable from divestiture 0 2,900
Contingent consideration from Permian Basin Sale 0 32,860
Dividends payable $ 317,530 $ 83,543